3,6,9,12,15-Pentaoxa-2-azaheptadecanoic acid, 17-amino-, 1,1-dimethylethyl ester manufacturers
|
| | 3,6,9,12,15-Pentaoxa-2-azaheptadecanoic acid, 17-amino-, 1,1-dimethylethyl ester Basic information |
| Product Name: | 3,6,9,12,15-Pentaoxa-2-azaheptadecanoic acid, 17-amino-, 1,1-dimethylethyl ester | | Synonyms: | 3,6,9,12,15-Pentaoxa-2-azaheptadecanoic acid, 17-amino-, 1,1-dimethylethyl ester;BocHNO-PEG4-CH2CH2NH2;Boc-HNO-PEG4-CH2CH2NH4;14-[(Boc-amino)oxy]-3,6,9,12-tetraoxatetradecan-1-amine | | CAS: | 2496687-02-4 | | MF: | C15H32N2O7 | | MW: | 352.42 | | EINECS: | | | Product Categories: | | | Mol File: | 2496687-02-4.mol |  |
| | 3,6,9,12,15-Pentaoxa-2-azaheptadecanoic acid, 17-amino-, 1,1-dimethylethyl ester Chemical Properties |
| density | 1.087±0.06 g/cm3(Predicted) | | pka | 8.74±0.10(Predicted) |
| | 3,6,9,12,15-Pentaoxa-2-azaheptadecanoic acid, 17-amino-, 1,1-dimethylethyl ester Usage And Synthesis |
| Uses | t-Boc-Aminooxy-PEG4-amine is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. | | IC 50 | PEGs | | References | [1] Nalawansha DA, et al. PROTACs: An Emerging Therapeutic Modality in Precision Medicine. Cell Chem Biol. 2020;27(8):998-985. DOI:10.7554/eLife.57277 |
| | 3,6,9,12,15-Pentaoxa-2-azaheptadecanoic acid, 17-amino-, 1,1-dimethylethyl ester Preparation Products And Raw materials |
|